{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:09:22Z","timestamp":1792728562717,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biomaterials.2022.121880","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T05:40:56Z","timestamp":1666849256000},"page":"121880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"291","author":[{"given":"Qiaofeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-1039","authenticated-orcid":false,"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.biomaterials.2022.121880_bib1","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6382","key":"10.1016\/j.biomaterials.2022.121880_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"7378","key":"10.1016\/j.biomaterials.2022.121880_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"10183","key":"10.1016\/j.biomaterials.2022.121880_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"issue":"7693","key":"10.1016\/j.biomaterials.2022.121880_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.biomaterials.2022.121880_bib6","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6371","key":"10.1016\/j.biomaterials.2022.121880_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2022.121880_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04605-x","article-title":"Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap","volume":"9","author":"Song","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121880_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802228","article-title":"Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"issue":"37","key":"10.1016\/j.biomaterials.2022.121880_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles to locally activate T cells in the tumor microenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci Immunol"},{"issue":"46","key":"10.1016\/j.biomaterials.2022.121880_bib11","article-title":"Recent progresses in phototherapy-synergized cancer immunotherapy","volume":"28","author":"Ng","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.biomaterials.2022.121880_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805888","article-title":"Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121880_bib13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121880_bib14","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1021\/acs.nanolett.9b01807","article-title":"Nanoenabled reversal of Ido1-mediated immunosuppression synergizes with immunogenic chemotherapy for improved cancer therapy","volume":"19","author":"Huang","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121880_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121880_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer\u2014how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121880_bib17","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/nn200007z","article-title":"Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells","volume":"5","author":"Wang","year":"2011","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121880_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrd3461","article-title":"Mining for therapeutic gold","volume":"10","author":"Collins","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7684","key":"10.1016\/j.biomaterials.2022.121880_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121880_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.drudis.2011.12.010","article-title":"Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)","volume":"17","author":"Cvek","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121880_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-12-163","article-title":"Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition","volume":"12","author":"Zha","year":"2014","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121880_bib22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS-MAPK and NF kappa B pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121880_bib23","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1039\/C7SC04853J","article-title":"Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophagemediated immunotherapy","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121880_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14338-5","article-title":"Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties","volume":"11","author":"Terashima","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2022.121880_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734853","article-title":"Disulfiram improves the anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121880_bib26","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121880_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.molonc.2015.02.007","article-title":"Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer","volume":"9","author":"Allensworth","year":"2015","journal-title":"Mol Oncol"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121880_bib28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121880_bib29","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1021\/nn4010796","article-title":"Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram","volume":"7","author":"Duan","year":"2013","journal-title":"ACS Nano"},{"issue":"29","key":"10.1016\/j.biomaterials.2022.121880_bib30","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1021\/jacs.9b03503","article-title":"Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition","volume":"141","author":"Wu","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121880_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2967\/jnumed.112.113324","article-title":"The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells","volume":"54","author":"Rae","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"17","key":"10.1016\/j.biomaterials.2022.121880_bib32","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.18632\/oncotarget.2166","article-title":"Liposome encapsulated Disulfiram inhibits NF\u03baB pathway and targets breast cancer stem cells in vitro and in vivo","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.biomaterials.2022.121880_bib33","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1002\/adfm.201201316","article-title":"Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery","volume":"22","author":"Zhang","year":"2012","journal-title":"Adv. Funct. Mater."},{"issue":"38","key":"10.1016\/j.biomaterials.2022.121880_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2022.121880_bib35","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.1522080113","article-title":"Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121880_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","article-title":"Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor","volume":"158","author":"Li","year":"2012","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121880_bib37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121880_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121880_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805730","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121880_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2009.11.008","article-title":"Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery","volume":"142","author":"Li","year":"2010","journal-title":"J. Contr. Release"},{"issue":"87","key":"10.1016\/j.biomaterials.2022.121880_bib41","first-page":"13334","article-title":"On the interaction of copper (II) with disulfiram","volume":"50","author":"Lewis","year":"2014","journal-title":"Chem"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121880_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121880_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and translational classifications of DAMPs in immunogenic cell death","volume":"6","author":"Garg","year":"2015","journal-title":"Front. Immunol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222005208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222005208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:13:49Z","timestamp":1758906829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222005208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":43,"alternative-id":["S0142961222005208"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121880","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121880"}}